Items where Author is "Regan, M. M."

2011

Viale, G. and Regan, M. M. and Dell'Orto, P. and Mastropasqua, M. G. and Maiorano, E. and Rasmussen, B. B. and MacGrogan, G. and Forbes, J. F. and Paridaens, R. J. and Colleoni, M. and Láng, I. and Thürlimann, B. and Mouridsen, H. and Mauriac, L. and Gelber, R. D. and Price, K. N. and Goldhirsch, A. and Gusterson, B. A. and Coates, A. S. and International Breast Cancer Study Groups, . (2011) Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Annals of oncology, Vol. 22, H. 10. pp. 2201-2207.

2008

Viale, G. and Regan, M. M. and Maiorano, E. and Mastropasqua, M. G. and Golouh, R. and Perin, T. and Brown, R. W. and Kovács, A. and Pillay, K. and Öhlschlegel, C. and Braye, S. and Grigolato, P. and Rusca, T. and Gelber, R. D. and Castiglione-Gertsch, M. and Price, K. N. and Goldhirsch, A. and Gusterson, B. A. and Coates, A. S.. (2008) Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer : predictive value of centrally reviewed expression of estrogen and progesterone receptors, international breast cancer study group. Journal of clinical oncology, Vol. 9. pp. 1404-1410.

Regan, M. M. and Pagani, O. and Walley, B. and Torrisi, R. and Perez, E. A. and Francis, P. and Fleming, G. F. and Price, K. N. and Thürlimann, B. and Maibach, R. and Castiglione-Gertsch, M. and Coates, A. S. and Goldhirsch, A. and Gelber, R. D.. (2008) Premenopausal endocrine-responsive early breast cancer : who receives chemotherapy? Annals of oncology, Vol. 19, H. 7. pp. 1231-1241.